G
Genelux Corp
GNLX
1.90000
USD
-0.06
(-3.06%)
مغلق
حجم التداول
2,609
الربح لكل سهم
0
العائد الربحي
0
P/E
-3
حجم السوق
111,376,894
الأخبار
العنوان: Genelux Corp
القطاع: Healthcare
الصناعة: Biotechnology
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.